Skip to content
Life Sciences Series B Founded 2017

Zyl Therapeutics

Developer of hydrogel-derived nanoparticle system for topical applications. The company has developed a patented drug delivery system Nanopods, a hydrogel-derived nanoparticle system. The system can be used to deliver payloads such as nitric oxide, curcumin, cannabis, siRNA, iron, and melanin topically. The company was founded in 2017 and headquartered in Greenville, United States. It has raised $9.4M in series b…

📍 Greenville, United States · Drug Delivery,

Funding snapshot

Last roundSeries B
Amount$263K
Date27 January 2025
Total raised$9M
Team size5

About

Developer of hydrogel-derived nanoparticle system for topical applications. The company has developed a patented drug delivery system Nanopods, a hydrogel-derived nanoparticle system. The system can be used to deliver payloads such as nitric oxide, curcumin, cannabis, siRNA, iron, and melanin topically. The company was founded in 2017 and headquartered in Greenville, United States. It has raised $9.4M in series b funding, with backing from NIH, VentureSouth, New York Angels, SCRA, and others. The company operates in the Life Sciences - Drug Delivery, High Tech - Nanotechnology space. Its offerings span Drug Delivery - Topical. The company's offerings encompass Drug Delivery - Topical.

Business model

Nanotechnology > Nanoenabled Products > Life Science > Drug Delivery > Encapsulation,

Drug Delivery > Topical

Institutional investors

NIH VentureSouth New York Angels SCRA Boston Harbor Angels Cowtown Angels HBS Alumni Angels of Greater New York NIH SBIR/STTR ASAP Chemical Angel Network HHS Arcview Collective Fund KTECH Capital AEON Foundry Mohan Growth Partners

Latest coverage

No articles yet.

Raising like Zyl Therapeutics?

Analyze your pitch deck before your next raise.

Analyze My Deck →